Blueshift Asset Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$6.23 - $8.57 $68,162 - $93,764
-10,941 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$5.31 - $8.31 $58,096 - $90,919
10,941 New
10,941 $91,000
Q1 2020

May 14, 2020
SELL
$2.61 - $5.21 $147,605 - $294,646
-56,554 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.67 - $5.7 $207,553 - $322,357
56,554 New
56,554 $212,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email